Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery

Steven E. Hill, Bob Broomer, John Stover, William White, William Richardson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND: Traditional techniques for obtaining hemostasis during orthopedic surgery, such as conventional electrocautery and sealants, have limited clinical effectiveness in reducing hemoglobin (Hb) loss and requirement for transfusion. The bipolar tissue sealant device studied in this trial combines radiofrequency energy with saline irrigation to hemostatically seal both cut bone and soft tissue, potentially aiding hemostasis. STUDY DESIGN AND METHODS: Sixty patients undergoing multilevel posterior lumbar instrumentation and fusion were randomly assigned to unipolar cautery alone (control group) or unipolar cautery plus use of the bipolar tissue sealant device (treatment group). Hb loss from the surgical field was measured (rather than estimated) and compared between the two groups. The primary hypothesis was that the treatment group would lose significantly less Hb than the control group. RESULTS: The control group experienced a mean Hb loss of 102.4 g while the treatment group showed a significantly lower mean Hb loss of 66.2 g (p = 0.0004). No significant difference was found between groups with respect to secondary endpoints including length of surgery, number of red blood cell units transfused, number of total blood component units transfused, transfusion avoidance, length of stay, or serious adverse events. CONCLUSION: Use of a bipolar tissue sealant device in addition to unipolar cautery significantly decreased Hb loss during multilevel, posterior lumbar spinal instrumentation and fusion when compared with unipolar cautery alone.

Original languageEnglish (US)
Pages (from-to)2594-2599
Number of pages6
JournalTransfusion
Volume52
Issue number12
DOIs
StatePublished - Dec 2012

Fingerprint

Cautery
Hemoglobins
Spine
Equipment and Supplies
Hemostasis
Control Groups
Spinal Fusion
Electrocoagulation
Orthopedics
Length of Stay
Therapeutics
Erythrocytes
Bone and Bones

ASJC Scopus subject areas

  • Hematology
  • Immunology
  • Immunology and Allergy

Cite this

Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. / Hill, Steven E.; Broomer, Bob; Stover, John; White, William; Richardson, William.

In: Transfusion, Vol. 52, No. 12, 12.2012, p. 2594-2599.

Research output: Contribution to journalArticle

Hill, Steven E. ; Broomer, Bob ; Stover, John ; White, William ; Richardson, William. / Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. In: Transfusion. 2012 ; Vol. 52, No. 12. pp. 2594-2599.
@article{43ce029903c4497b90779de5c3bdeed2,
title = "Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery",
abstract = "BACKGROUND: Traditional techniques for obtaining hemostasis during orthopedic surgery, such as conventional electrocautery and sealants, have limited clinical effectiveness in reducing hemoglobin (Hb) loss and requirement for transfusion. The bipolar tissue sealant device studied in this trial combines radiofrequency energy with saline irrigation to hemostatically seal both cut bone and soft tissue, potentially aiding hemostasis. STUDY DESIGN AND METHODS: Sixty patients undergoing multilevel posterior lumbar instrumentation and fusion were randomly assigned to unipolar cautery alone (control group) or unipolar cautery plus use of the bipolar tissue sealant device (treatment group). Hb loss from the surgical field was measured (rather than estimated) and compared between the two groups. The primary hypothesis was that the treatment group would lose significantly less Hb than the control group. RESULTS: The control group experienced a mean Hb loss of 102.4 g while the treatment group showed a significantly lower mean Hb loss of 66.2 g (p = 0.0004). No significant difference was found between groups with respect to secondary endpoints including length of surgery, number of red blood cell units transfused, number of total blood component units transfused, transfusion avoidance, length of stay, or serious adverse events. CONCLUSION: Use of a bipolar tissue sealant device in addition to unipolar cautery significantly decreased Hb loss during multilevel, posterior lumbar spinal instrumentation and fusion when compared with unipolar cautery alone.",
author = "Hill, {Steven E.} and Bob Broomer and John Stover and William White and William Richardson",
year = "2012",
month = "12",
doi = "10.1111/j.1537-2995.2012.03649.x",
language = "English (US)",
volume = "52",
pages = "2594--2599",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery

AU - Hill, Steven E.

AU - Broomer, Bob

AU - Stover, John

AU - White, William

AU - Richardson, William

PY - 2012/12

Y1 - 2012/12

N2 - BACKGROUND: Traditional techniques for obtaining hemostasis during orthopedic surgery, such as conventional electrocautery and sealants, have limited clinical effectiveness in reducing hemoglobin (Hb) loss and requirement for transfusion. The bipolar tissue sealant device studied in this trial combines radiofrequency energy with saline irrigation to hemostatically seal both cut bone and soft tissue, potentially aiding hemostasis. STUDY DESIGN AND METHODS: Sixty patients undergoing multilevel posterior lumbar instrumentation and fusion were randomly assigned to unipolar cautery alone (control group) or unipolar cautery plus use of the bipolar tissue sealant device (treatment group). Hb loss from the surgical field was measured (rather than estimated) and compared between the two groups. The primary hypothesis was that the treatment group would lose significantly less Hb than the control group. RESULTS: The control group experienced a mean Hb loss of 102.4 g while the treatment group showed a significantly lower mean Hb loss of 66.2 g (p = 0.0004). No significant difference was found between groups with respect to secondary endpoints including length of surgery, number of red blood cell units transfused, number of total blood component units transfused, transfusion avoidance, length of stay, or serious adverse events. CONCLUSION: Use of a bipolar tissue sealant device in addition to unipolar cautery significantly decreased Hb loss during multilevel, posterior lumbar spinal instrumentation and fusion when compared with unipolar cautery alone.

AB - BACKGROUND: Traditional techniques for obtaining hemostasis during orthopedic surgery, such as conventional electrocautery and sealants, have limited clinical effectiveness in reducing hemoglobin (Hb) loss and requirement for transfusion. The bipolar tissue sealant device studied in this trial combines radiofrequency energy with saline irrigation to hemostatically seal both cut bone and soft tissue, potentially aiding hemostasis. STUDY DESIGN AND METHODS: Sixty patients undergoing multilevel posterior lumbar instrumentation and fusion were randomly assigned to unipolar cautery alone (control group) or unipolar cautery plus use of the bipolar tissue sealant device (treatment group). Hb loss from the surgical field was measured (rather than estimated) and compared between the two groups. The primary hypothesis was that the treatment group would lose significantly less Hb than the control group. RESULTS: The control group experienced a mean Hb loss of 102.4 g while the treatment group showed a significantly lower mean Hb loss of 66.2 g (p = 0.0004). No significant difference was found between groups with respect to secondary endpoints including length of surgery, number of red blood cell units transfused, number of total blood component units transfused, transfusion avoidance, length of stay, or serious adverse events. CONCLUSION: Use of a bipolar tissue sealant device in addition to unipolar cautery significantly decreased Hb loss during multilevel, posterior lumbar spinal instrumentation and fusion when compared with unipolar cautery alone.

UR - http://www.scopus.com/inward/record.url?scp=84870976637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870976637&partnerID=8YFLogxK

U2 - 10.1111/j.1537-2995.2012.03649.x

DO - 10.1111/j.1537-2995.2012.03649.x

M3 - Article

C2 - 22500572

AN - SCOPUS:84870976637

VL - 52

SP - 2594

EP - 2599

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 12

ER -